While GLP-1 compounding has changed, liraglutide gives us a great new option
There is a growing frequency of antibiotic treatment failure among patients with NTHi-associated infections, largely owing to a rapidly evolving resistance profile (Sriram et al., 2017)
rotate: Lamiophlomis rotate SM: Shanzhiside methylester MAPK: p38 mitogen-activated protein kinase DPN: Diabetic peripheral neuropathy MCU: Mitochondrial calcium uniporter UCP3: Uncoupling protein 3 DRP1: Dynamin-related protein 1 STZ: Streptozotocin ERK: Extracellular signal-regulated kinase MMP-2: Matrix metalloproteinases-2 MMP-9: Matrix metalloproteinases-9 NLRP3: NOD-like receptor protein 3 AGEs: Advanced glycation end products CSA: Cross-sectional area CM: Chronic migraine TNC: Trigeminal nucleus caudalis CGRP: Calcitonin gene-related peptide ICP: Intracranial pressure CSF: Cerebrospinal fluid IIH: Idiopathic intracranial hypertension References Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, Gao J (2024) Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
As interest has exploded, so has the number of women turning to the gray market to buy products from unregulated sources, without fully understanding what these compounds are, how they're supposed to work, or the potential risks involved
